ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 85 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $24,603,000 | -68.0% | 460,299 | -32.4% | 0.01% | -69.6% |
| Q4 2015 | $76,956,000 | +39.4% | 681,213 | +45.2% | 0.02% | +35.3% |
| Q3 2015 | $55,219,000 | +182.2% | 469,098 | +85.6% | 0.02% | +240.0% |
| Q2 2015 | $19,568,000 | -42.4% | 252,719 | -57.0% | 0.01% | -44.4% |
| Q1 2015 | $33,991,000 | +0.4% | 587,566 | -44.0% | 0.01% | 0.0% |
| Q4 2014 | $33,839,000 | +15.7% | 1,049,266 | -12.2% | 0.01% | +12.5% |
| Q3 2014 | $29,241,000 | +38.9% | 1,194,952 | +0.7% | 0.01% | +166.7% |
| Q2 2014 | $21,046,000 | +101.9% | 1,187,102 | +127.8% | 0.00% | 0.0% |
| Q1 2014 | $10,426,000 | +219.7% | 521,010 | +168.1% | 0.00% | +200.0% |
| Q4 2013 | $3,261,000 | -21.0% | 194,353 | -50.0% | 0.00% | 0.0% |
| Q3 2013 | $4,128,000 | +530.2% | 388,530 | +231.5% | 0.00% | – |
| Q2 2013 | $655,000 | – | 117,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |